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1 Introduction
Fetal growth is exponential, and the mechan-
isms that regulate fetal growth in humans is
poorly understood. It has been suggested that
fetal growth is influenced by genetic, nutrition-
al, environmental, uteroplacental and fetal fac-
tors [11], In Japan, the fetal growth retardation
and low birth weight infants make up about 10
percent of all deliveries, and their morbidity
and mortality are very high in comparison with
normal babies.
From a clinical point of view, to reduce the
incidence of intrauterine growth retardation,
we introduced maltose-infusion therapy and
have had good clinical results in increasing fetal
weight and decreasing neonatal hypoglycemia.
We found decreased levels of aspartic acid in
umbilical arterial blood and increased levels of
phenylalanine in umbilical venous and arterial
blood. These results suggested that the clinical
efficiency of maltose-infusion therapy was
based not only on the increased supply of gluco-
se but also on the efficient use of transported
amino acid in the fetus [7].
Therefore as information concerning the mech-
anisms regulating normal fetal growth enables
us to prevent or to treat growth retardation, in
this paper an attempt was made to investigate
the mechanism of growth promoting action of
somatomedin-C, which is one of the most popu-
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lar growth factors [9], in relation to the amino
acid composition of umbilical venous blood
and several parameters of the neonate.
2 Materials and methods
Blood samples from the umbilical vein were
obtained from 28 cases. They were withdrawn
into disposable syringes and distributed to ves-
sels containing EDTA for the analysis of amino
acids and somatomedin-C, respectively. All
blood samples were centrifuged immediately at
3000 rpm for 20 minutes. They were then trans-
ported to separate vessels, and kept in a frozen
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state at — 70 °C until analysis. The sera were
deprotenized with sulfosalicylic acid (20%), and
amino acid analysis of 20 specimens were per-
formed with two-column ion exchange chroma-
tography using an automatic amino acid analy-
zer (Hitachi, model 835). Levels of somato-
medin-C were determined by radioimmunoas-
say (Nichols Institute, USA). Evaluation of fet-
al growth was based upon NISHIDA'S
intrauterine growth curve for Japanese neo-
nates [6].
Statistical significance was assessed using
Mann-Whitney U test to make inter-group
comparisons. The linear correlation coefficient,
the slope, the intercept and the significance
level were evaluated with the Statistical Package
for Social Science (SPSS) of Northwestern Uni-
versity. Abnormal values were treated by
Grubb's method.
3 Results
The comparison of mean value of somato-
medin-C between appropriate for date (AFD)
babies and small for date (SFD) babies in full
term pregnancy showed significantly higher
levels in AFD babies (figure 1).
We also evaluated other parameters of the neo-
nate (birth weight, birth length, head circumfer-
ence, chest circumference and Kaup index
[x 10]) in AFD babies (table I). But only the
birth weight in the physical parameters of the
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Figure 1. Somatomedin-C in cord blood of full term
pregnancy of appropriate for date babies (AFD) and
small for date babies (SFD).
neonate (figure 2) and the placental weight for
AFD babies including full term and preterm
pregnancy had significant positive correlations
with the level of somatomedin-C in cord blood
(table I).
The mean and the standard deviation of amino
acids in umbilical venous blood are presented
in table II, but the comparison of mean value
of each amino acid between AFD babies and
Table I. Correlations between the level of somatomedin-C in cord blood and physical parameters of the neonate
including placental weight.
n
Somatomedin-C vs.
Somatomedin-C vs.
Somatomedin-C vs.
Somatomedin-C vs.
Somatomedin-C vs.
Somatomedin-C vs.
birth weight
birth length
head circumference
chest "circumference
Kaup index ( χ 10)
placental weight
19
14
14
14
14
18
0.556
0.123
0.184
0.387
0.451
0.595
<0.02
n. s.
n. s.
n. s.
n. s.
<0.01
Note: All these data were obtained from appropriate for date babies including full term and preterm babies, but
birth weight of one case for preterm appropriate for date baby was omitted due to inappropriate date of measuring
the birth weight.
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Figure 2. Relationship between the level of somato-
medin-C in cord blood and birth weight of appropriate
for date babies for full term (·) and preterm (O) deliver-
ies. Cases with small for date babies also indicated for
full term pregnancies (·) and for preterm pregnancies
(D).
SFD babies showed no significant difference in
this series.
Of the 40 amino acids and their analogues,
somatomedin-C for AFD babies had significant
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Figure 3. Relationship between the level of somato-
medin-C in cord blood and the concentration of gluta-
min in cord blood of appropriate for date babies (indi-
cated with closed circles). Open circles indicate cases
with small for date babies.
positive correlation with glutamine (r = 0.685,
ρ < 0.01, figure 3), proline (r = 0.657,
ρ < 0.02), asparagine (r = 0.590, ρ < 0.02),
methionine (r = 0.575, ρ < 0.02), isoleucine
(r = 0.574, ρ < 0.03) and ethanolamine
(r = 0.711, ρ < 0.01). While significant nega-
tive correlation was found only tryptophane
and somatomedin-C (r = —0.555, ρ < 0.03,
figure 4) (table III).
Table Π. The means and their standard deviations of amino acid concentration in cord blood in AFD and SFD
babies.
Amino acid AFD(n = 13) SFD (n = 7) Amino acid AFD (n = 13) SFD (n = 7)
Taurine
Aspartic acid
Hydroxy Prolin
Threonine
Serine
Asparagine
Glutamic acid
Glutamine
Proline
Glycine
Alanine
Citrulline
A-A. B. A.
Valine
2.43 + 0.77
0.14 ± 0.09
0.42 + 0.13
2.78 + 0.96
1.74 + 0.32
0.95 + 0.30
1.56 + 1.13
5.91 + 1.52
2.21 + 0.52
1.82 ± 0.37
4.31 + 1.39
0.16 + 0.05
0.17 + 0.07
2.80 ± 0.75
2.74 + 0.55
0.14 + 0.09
0.37 + 0.04
3.05 + 0.92
1.75 + 0.17
1.02 + 0.17
1.29 + 0.95
7.03 + 2.33
2.11 ± 0.39
1.91 + 0.37
4.20 ± 1.20
0.15 + 0.04
0.18 + 0.07
2.96 + 0.64
Cystine
Methionine
Isoleucine
Leucine
Tyrosine
Phenylalanine
Ethanolamine
Ornithine
Tryptophane
Lysine
Histidine
3-Methylhistidine
Arginine
NH3
0.19 + 0.14
0.46 + 0.11
0.94 + 0.28
1.63 ± 0.52
1.41 + 0.43
1.49 + 0.38
0.25 + 0.11
1.15 + 0.36
1.16 + 0.37
4.96 + 1.24
1.65 + 0.35
0.09 + 0.05
1.08 + 0.43
0.44 + 0.14
0.23 + 0.10
0.47 + 0.09
0.95 + 0.14
1.72 + 0.30
1.39 + 0.37
1.44 + 0.30
0.19 + 0.04
1.19 + 0.31
1.16 + 0.43
5.45 ± 1.52
1.61 + 0.47
0.11 + 0.05
1.36 ± 0.32
0.44 ± 0.21
Note: AFD: Appropriate for date babies, SFD: Small for date babies, Α—Α. Β. Α.: Alpha-Amino-n-butyric acid.
One case of proline in both groups and one case of ethanolamine (mean ± S. D., mg/dl) in SFD group were
rejected due to their abnormalities.
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Figure 4. Relationship between the level of somato-
\medin-C in cord blood and the concentration of trypto-
phane in cord blood of appropriate for date babies
(indicated with closed circles). Open circles indicate cases
with small for date babies.
In small for date babies, the evaluation of the
linear regression analysis of each amino acid
and their analogues in relation to somato-
medin-C revealed that only glutamine
(r = 0.764, p < 0.03, figure 3) demonstrated a
significant positive correlation, but also reveal-
ed that tryptophane showed a significant nega-
tive correlation (r = —0.737, p < 0.03, figure
4) not only in AFD babies but also in SFD
babies. As for the methionine somatomedin-C
correlation, there was an almost significant
trend (r = 0.662, p < 0.052) for the SFD ba-
bies (table III).
4 Discussion
Somatomedin-C is a basic polypeptide and al-
though not yet fully characterized, bears strik-
ing similarities to insulinlike growth factor. In
differentiated cells such as fat and muscle, the
somatomedins stimulate glucose and amino
acid uptake, glycolysis, and protein synthesis
[10]. A very reliable specificity can be achieved
with radioimmunoassay which has recently be-
en developed for all somatomedins [10].
The demonstration of the significant positive
correlation between somatomedin-C and birth
weight in AFD babies suggests a role for
somatomedin-C in the control of normal fetal
growth. Similar findings have been reported by
KASTRUP et al [5] and GLUCKMAN et al [3], who
also found a positive correlation not only with
birth weight but also with body length and head
circumference.
Our observation of the significantly lower level
of somatomedin-C in growth retarded babies
in comparison to AFD babies in full term preg-
nancy has confirmed the importance of somato-
medin-C for the adequate fetal growth in utero,
and it agrees with the report of FOLEY et al [2]
in which the somatomedin activity as measured
by the simultaneous incorporation of 35S-sul-
phate and 3H-methyl thymidine into costal car-
tilage from hypophysectomised rat. We also
obtained a significant positive correlation be-
tween somatomedin-C and placental weight for
AFD babies. This correlation appeared not to
be present in SFD babies. KASTRUP et al [5]
Table HI. Correlations between somatomedin-C and amino acids.
Glutamine
Methionine
Proline
Asparagine
Isoleucine
Ethanolamine
Tryptophane
AFD(n=13)
r
0.685
0.575
0.657
0.590
0.574
0.71"!
- 0.555
Ρ
<0.01
<0.02
<0.02
< 0.02
<0.03
< 0.01
<0.03
SFD(n = 7)
r
0.764
0.662
0.567
- 0.148
- 0.148
0.256
- 0.737
Ρ
< 0.03
< 0.052
n. s.
n. s.
n. s.
N. S. (n
< 0.03
= 6)
Note: AFD: Appropriate for date babies, SFD: Small for date babies. One case of proline m both groups was
rejected due to its abnormality.
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reported no significant correlation between
cord somatomedin, which was determined by
chick embryo assay, and placental weight.
D'ERCOLE and UNDERWOOD [1] observed a cor-
relation of placental weight with somato-
medin-C.
This is the first report, to our knowledge, con-
cerning the relationship between somatomedin-
C and amino acid in human fetuses. Our data
demonstrated four correlations which were sig-
nificantly positive for AFD babies, but the cor-
relation does not exist for SFD babies. This
change of proline could be a suggestion of
metabolic disturbances in proline components
of collagen in growth retarded fetuses, because
normally, proline with hydroxy proline consti-
tutes 2/3 of the amino acid component of colla-
gen. Since the mean value of any amino acid
from AFD babies did not show any significant
difference from that of SFD babies (which is
in agreement with the report of PRENTON and
YOUNG [8]), these changes of amino acids corre-
lations including proline could not be explained
clearly. There also seems to be many other
problems to be clarified: the change of sensitiv-
ity to somatomedin-C of each organ and of
each tissue during fetal development.
Our results also demonstrated a constant posi-
tive correlation between somatomedin-C and
glutamine (main source of proline in almost all
mammals) and the constant negative correla-
tion between somatomedin-C and tryptophane.
The continuity of positive correlation seemed
to be found also in the relationship between
somatomedin-C and methionine, which is the
precursor of 1,3-diaminopropane that consti-
tutes a part of spermidine and spermine.
Is there any possible explanation for the con-
stant correlations for these three amino acids
in relation to somatomedin-C? It is easy to
identify these correlations were pseudo-rela-
tions. On the basis of the fact that hepatic
tryptophane hydroxylase to the hydroxy deriva-
tives is analoguous to the conversion to tyrosine
from phenylalanine, and on the basis of signifi-
cantly higher levels of phenylalanine on the
fetal side, (but not the extent of maternal phe-
nylketonuria) with maltose infusion during the
therapy for intrauterine fetal growth retarda-
tion, this appears to be one of the possible keys
of explaining these relationships, especially for
tryptophane. Incidentally it should be noted
that tryptophane pyrrolase which catalizes
tryptophane kynurenic acid is inactive during
fetal life.
Since the regulation of somatomedins, which
was originally thought to be done solely by
growth hormone, has proved to be sufficiently
complex that nutrition and various hormones,
such as insulin, exert a partial control [4], it is
difficult to have a simple explanation for these
results.
While our subject population was rather small
and many details of these relationships are not
clear, the results of this report lead us to specu-
late that somatomedin-C as a growth promot-
ing factor in the fetus has some relationship
with metabolites of tryptophane, for example
serotonin and or melatonine, in regulating fetal
growth in utero.
A follow up study to investigate these specula-
tions with better experimental models and with
more parameters is now in progress.
Summary
A study was undertaken to determine the relationship
of somatomedin-C as a growth promoting factor to
amino acid composition of umbilical venous blood in
relationship to fetal growth.
In full term pregnancy somatomedin-C from cases with
appropriate fetal growth was greater than those with
fetal growth retardation. Within the physical parameters
of the neonate only birth weight of appropriate for date
babies had significant positive relationship to somato-
medin-C in cord blood. Of the 40 amino acids and their
analogues, significant positive correlations were found
for glutamine, prolin, asparagin, methionin, isoleucin
and ethanolamine in relation to the level of somatomed-
in-C, while a significant negative correlation was found
between tryptophane and somatomedin-C of appropri-
ate for date babies. In cases with fetal growth retarda-
tion, the evaluation of amino acid-somatomedin-C
relationship revealed that glutamine demonstrated a sig-
J. Perinat. Med. 14 (1986)
168 Nishijima, Somatomedin-C as a fetal growth promoting factor
nificant positive correlation and tryptophane demon-
strated a significant negative correlation.
While many details of these relationships are not clear,
the results of this report lead us to speculate that somato-
medin-C as a growth promoting factor in the fetus has
some relationship to metabolites of tryptophane, for
example serotonine and or melatonine, in regulating
fetal growth in utero.
Keywords: Amino acid, fetus, growth factor, somatomedin-C.
Zusammenfassung
Somatomedin-C als wachstumsfördernder Faktor beim
Feten und Aminosäurespektrum im Nabelschnurblut bei
japanischen Neugeborenen
In der vorliegenden Studie sollte untersucht werden,
welcher Zusammenhang zwischen dem Somatomedin-C
als Wachstumshormon und der Aminosäurezusammen-
setzung im Nabelvenenblut in Bezug auf das fetale
N Wachstum besteht.
Bei Schwangerschaften am Termin war die Somato-
medin-C-Konzentration bei normalgewichtigen Kindern
höher als bei Fällen mit fetaler Wachstumsretardierung.
Innerhalb der somatischen Parameter wies lediglich das
Geburtsgewicht der am Termin entbundenen Kinder eine
signifikante, positive Korrelation zum Somatomedin-C-
Spiegel im Nabelvenenblut auf. Bezüglich der 40 Amino-
säuren und ihrer Abkömmlinge wurde eine signifikante,
positive Korrelation zur Somatomedin-C-Konzentration
gefunden für: Glutamin, Prolin, Asparagin, Methionin,
Isoleucin und Äthanolamin. Eine signifikant negative
Korrelation hingegen bestand bei Kindern am Termin
zwischen der Tryptophankonzentration und dem Soma-
tomedin-C-Spiegel. Bei Wachstumsretardierung ergaben
die Untersuchungen eine signifikant positive Korrelation
in Bezug auf das Glutamin und eine signifikant negative
Korrelation in Bezug auf das Tryptophan.
Trotz vieler offener Fragen läßt sich aus den Ergebnissen
der Studie folgende Hypothese ableiten: Bei der Regula-
tion des fetalen Wachstums in utero besteht ein Zusam-
menhang zwischen dem Somatomedin-C als wachstums-
förderndem Faktor und einigen Tryptophan-Metaboli-
ten, wie z. B. Serotonin und/oder Methionin.
Schlüsselwörter: Aminosäuren, Fetus, Somatomedin-C, Wachstumsfaktor.
Resume
Somatomedine C comme facteur de promotion de la
croissance fetale et composition en acides amines du sang
du cordon chez les nouveaux-nes japonais
On realise une etude pour determiner la relation de la
somatomedine C comme facteur de promotion de la
croissance avec la composition en acides amines du sang
veineux ombilical en relation avec la croissance foetale.
Chez les grossesses a terme, la somatomedine C est plus
elevee dans les cas ou la croissance foetale est normale
que dans les cas avec retard de croissance. Parmi les
parametres cliniques, seul le poids de naissance des en-
fants a poids normal pour le terme a une relation positive
significative avec la somatomedine C au sang du cordon.
Parmi les 40 acides amines et leurs analogues, on a
trouve des correlations positives significatives pour la
glutamine, la proline, 1'asparagine, la methionine, 1'iso-
leucine et Pethanolamine avec le taux de somatomedine
C, alors qu'on a trouve une correlation negative signifi-
cative entre le tryptophane et la somatomedine C chez
les enfants avec tin poids normal pour le terme. Dans
les cas de retard de croissance intra-uterin, 1'evaluation
de la relation entre acides amines et somatomedine C a
revele qu'il existe une correlation positive significative
avec la glutamine et une correlation negative significative
avec le tryptophane.
Bien que de nombreux details au niveau de ces relations
ne soient pas clairs, les resultats de ce rapport nous
conduisent ä speculer que la somatomedine C en tant
que facteur de promotion de la croissance chez le foetus
a certaines relations avec des metabolites du tryptopha-
ne, par exemple avec la serotine et/ou la melatonine
dans la regulation de la croissance foetale in utero.
Mots-cSes: Acides amines, facteurs de croissance, foetus, somatomedine C.
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